JAK / Stat

Items 151 to 200 of 218 total

per page
Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Set Descending Direction
  1. Butein

    Catalog No. A12448
    Quick View
    Butein is a plant polyphenol that acts as a specific protein tyrosine kinase inhibitor. Learn More
  2. SU-5402

    Catalog No. A11558
    Quick View
    VEGFR/FGFR/EGFR inhibitor‎
    SU-5402 is a potent and selective vascular endothelial growth factor receptor (VEGFR) and fibroblast growth factor receptor (FGFR) inhibitor (IC50 values are 0.02, 0.03, 0.51 and > 100 μM at VEGFR2, FGFR1, PDGFRβ and EGFR respectively). Learn More
  3. PKC 412 (Midostaurin)

    Catalog No. A12650
    Quick View
    PKC inhibitor
    PKC 412 is a broad spectrum protein kinase inhibitor. Inhibits conventional PKC isoforms α/β/γ, PDFRβ, VEGFR2, Syk, Flk-1, Flt3, Cdk1/B, PKA, c-Kit, c-Fgr, c-Src, VEGFR1 and EGFR. Displays potent antitumor activity. Learn More
  4. CGP-52411

    Catalog No. A12867
    Quick View
    EGFR inhibitor
    CGP-52411 is a slective inhibitor of the epidermal growth factor receptor (EGFR) (IC50 = 0.3 μM in vitro). Also inhibits and reverses the formation of Aβ42 fibers associated with Alzheimer's disease. Learn More
  5. ARRY-543 (Varlitinib, ASLAN001)

    Catalog No. A12868
    Quick View
    ErbB inhibitor
    ARRY-543 is a novel, oral ErbB family inhibitor that, unlike approved ErbB inhibitors, targets all members of the ErbB family, including ErbB3, either directly or indirectly, and has potential advantages in treating tumors that signal through multiple ErbB family members. Learn More
  6. CO-1686 (Rociletinib, AVL-301)

    Catalog No. A13028
    Quick View
    EGFR inhibitor
    CO-1686 is a novel, oral, targeted covalent (irreversible) inhibitor of the cancer-causing mutant forms of epidermal growth factor receptor (EGFR) currently being studied for the treatment of non-small cell lung cancer (NSCLC). Learn More
  7. Icotinib Hydrochloride

    Catalog No. A13718
    Quick View
    EGFR inhibitor
    Icotinib hydrochloride is a potent and specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) with an IC(50) of 5 nM, including it's mutants of EGFR(L858R), EGFR(L861Q), EGFR(T790M) and EGFR(T790M, L858R). Learn More
  8. AZD-9291 (Osimertinib)

    Catalog No. A13681
    Quick View
    EGFR inhibitor
    AZD-9291 is a third-generation EGFR inhibitor, showed promise in preclinical studies and provides hope for patients with advanced lung cancers that have become resistant to existing EGFR inhibitors. Learn More
  9. Tyrphostin AG 183

    Catalog No. A13588
    Quick View
    EGFR inhibitor
    Tyrphostin AG 183 inhibits EGFR (epidermal growth factor receptor) tyrosine kinase (IC50 = 800 nM). Learn More
  10. CNX-2006

    Catalog No. A13755
    Quick View
    EGFR inhibitor
    CNX-2006 is a potent, mutant-selective EGFR inhibitor with excellent in vitro activity in cells with activating EGFR mutations, as well as in cells harbouring the T790M mutation. CNX-2006 is the prototype for CO-1686, which is currently in a Phase I clinical trial for the treatment of EGFR-mutant lung cancer. Learn More
  11. Icotinib

    Catalog No. A13825
    Quick View
    EGFR inhibitor
    Icotinib is a potent and specific EGFR inhibitor with IC50 of 5 nM, including the EGFR, EGFR(L858R), EGFR(L861Q), EGFR(T790M) and EGFR(T790M, L858R). Learn More
  12. (-)-Gallocatechin

    Catalog No. A12003
    Quick View
    (-)-Gallocatechin possesses free radical scavenging ability. It inhibits the growth and adherence of P. gingivalis onto the buccal epithelial cells. Learn More
  13. Poziotinib

    Catalog No. A13044
    Quick View
    EGFR inhibitor
    Poziotinib is an orally bioavailable, quinazoline-based pan epidermal growth factor receptor (EGFR or HER) inhibitor with potential antineoplastic activity. Learn More
  14. EGFR Inhibitor

    Catalog No. A13673
    Quick View
    EGFR Inhibitor
    EGFR inhibitor is a cell permeable, 4,6-disubstituted pyrimidine compound that selectively inhibits the EGFR kinase with an IC50 value of 21 nM in vitro and blocks receptor autophosphorylation in cells. Learn More
  15. Epidermal Growth Factor Receptor Peptide (985-996)

    Catalog No. A14877
    Quick View
    Epidermal Growth Factor Receptor Peptide (985-996) exists on the cell surface and is activated by the binding of its specific ligands, including epidermal growth factor and transforming growth factor. Learn More
  16. Compound 56

    Catalog No. A14953
    Quick View
    EGFR inhibitor
    Compound 56 is a cell-permeable, reversible, and ATP-competitive inhibitor of tyrosine kinase activity of EGFR. Learn More
  17. Afatinib dimaleate

    Catalog No. A14985
    Quick View
    EGFR inhibitor
    Afatinib is an irreversible EGFR/HER2 inhibitor with an IC50 of 14 nM for in vitro potency against HER2. Learn More
  18. Erlotinib mesylate

    Catalog No. A15081
    Quick View
    EGFR inhibitor
    Erlotinib mesylate is a directly acting inhibitor of human EGFR tyrosine kinase with an IC50 of 2 nM. Learn More
  19. Gefitinib hydrochloride

    Catalog No. A15093
    Quick View
    EGFR Inhibitor
    Gefitinib hydrochloride is an EGFR inhibitor, which interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells. Therefore, it is only effective in cancers with mutated and overactive EGFR. Learn More
  20. Vandetanib trifluoroacetate

    Catalog No. A15272
    Quick View
    VEGFR/EGFR inhibitor
    Vandetanib is a potent inhibitor of VEGFR2 with IC50 of 40 nM. Learn More
  21. WHI-P180

    Catalog No. A15509
    Quick View
    EGFR/Cdk2 inhibitor
    WHI-P180 is a potent EGFR and Cdk2 inhibitors with IC50 of 4.0 and 1.0 uM, respectively. Learn More
  22. AZ5104

    Catalog No. A15516
    Quick View
    EGFR inhibitor
    AZ5104, the demethylated metabolite of AZD-9291, is a potent EGFR inhibitor with IC50 of <1 nM, 6 nM, 1 nM, and 25 nM for EGFR (L858R/T790M), EGFR (L858R), EGFR (L861Q), and EGFR (wildtype), respectively. Phase 1. Learn More
  23. D-69491

    Catalog No. A15457
    Quick View
    HER2 inhibitor
    D-69491 (SU11464) is a small-molecule HER2 inhibitor, which was under development for the treatment of tumours with high expression of HER2, such as breast, ovarian, lung and pancreatic carcinomas. Learn More
  24. AZD3759

    Catalog No. A15551
    Quick View
    EGFR inhibitor
    AZD3759 is an orally available inhibitor of the epidermal growth factor receptor (EGFR). It binds to and inhibits the activity of EGFR as well as certain mutant forms of EGFR. Learn More
  25. ASP8273 (Naquotinib)

    Catalog No. A14408
    Quick View
    irreversible EGFR inhibitor
    ASP8273 is an orally available, irreversible, third-generation, mutant-selective, epidermal growth factor receptor (EGFR) inhibitor, with potential antineoplastic activity. Learn More
  26. EGF816 (Nazartinib)

    Catalog No. A14416
    Quick View
    EGFR T790M inhibitor
    EGF816 is a novel covalent inhibitor of mutant-selective EGFR; overcomes T790M-mediated resistance in NSCLC. Learn More
  27. CL-387785 (EKI-785)

    Catalog No. A13146
    Quick View
    EGFR inhibitor
    CL-387785 is an irreversible inhibitor of EGFR with IC50 of 370+/-120 pM; is able to overcome resistance caused by the T790M mutation on a functional level. Learn More
  28. AG-18 (Tyrphostin 23)

    Catalog No. A15940
    Quick View
    EGFR Inhibitor
    AG-18 is an inhibitor of epidermal growth factor (EGF) receptor kinase with an IC50 value of 35 ,M in the human epidermoid carcinoma cell line A431. Learn More
  29. DM1-SMCC

    Catalog No. A15955
    Quick View
    potent EGFR inhibitor
    DM1-SMCC is DM1 with a reactive linker SMCC, which can react with antibody to make antibody drug conjugate. Learn More
  30. PD168393

    Catalog No. A12725
    Quick View
    EGFR inhibitor
    PD168393 is a potent, cell-permeable, irreversible inhibitor of EGFR with IC50 value of 700 pM. Learn More
  31. EAI045

    Catalog No. A16193
    Quick View
    EGFR inhbitor
    EAI045 ia a potent and selective EGFR inhbitor. EAI045 targets selected drug-resistant EGFR mutants but spares the wild-type receptor. Learn More
  32. Anlotinib

    Catalog No. A16253
    Quick View
    EGFR inhibitor
    Anlotinib is a EGFR inhibitor extracted from patent 2015185012 A1, compound 1,which can be used to treat non-small cell lung cancer. Learn More
  33. PD158780

    Catalog No. A16254
    Quick View
    EGFR inhibitor
    PD158780 is a very potent inhibitor of EGFR with IC50 of 0.08 nM; pan-specific antagonist of ErbB receptor. Learn More
  34. TX1-85-1

    Catalog No. A16361
    Quick View
    Her3 (ErbB3) ligand
    TX1-85-1 is ErbB3 inhibitor. TX2-121-1 may exert Her3-dependent pharmacology through an allosteric mechanismthereby disrupting interactions between Her3 and other proteins such as Her3 or cMet consistent with results presented here and distinct from conventional kinase inhibitors, which block catalytic function. Learn More
  35. ARRY-380 (Irbinitinib)

    Catalog No. A16413
    Quick View
    HER2 inhibitor
    ARRY-380 is an orally bioavailable inhibitor of the human epidermal growth factor receptor tyrosine kinase ErbB-2 (also called HER2) with potential antineoplastic activity. Learn More
  36. Erlotinib

    Catalog No. A11416
    Quick View
    EGFR inhibitor
    Erlotinib is an epidermal growth factor receptor inhibitor (EGFR inhibitor). Erlotinib HCl was approved. Erlotinib binds in a reversible fashion to the adenosine triphosphate (ATP) binding site of the receptor. For the signal to be transmitted, two EGFR molecules need to come together to form a homodimer. These then use the molecule of ATP to trans-phosphorylate each other on tyrosine residues, which generates phosphotyrosine residues, recruiting the phosphotyrosine-binding proteins to EGFR to assemble protein complexes that transduce signal cascades to the nucleus or activate other cellular biochemical processes. When erlotinib binds to EGFR, formation of phosphotyrosine residues in EGFR is not possible and the signal cascades are not initiated. Learn More
  37. AG-1517

    Catalog No. A13001
    Quick View
    EGFR inhibitor
    AG 1517 is a potent and selective ATP competitive inhibitor of the epidermal growth factor receptor tyrosine kinase EGFR. Learn More
  38. AV412

    Catalog No. A15460
    Quick View
    EGFR inhibitor
    AV-412 (MP412) is an EGFR inhibitor with IC50s of 0.75, 0.5, 0.79, 2.3, 19 nM for EGFR, EGFRL858R, EGFRT790M, EGFRL858R/T790M?and ErbB2, respectively. Learn More
  39. Avitinib (AC0010)

    Catalog No. A16826
    Quick View
    irreversible EGFR inhibitor
    Avitinib (AC0010) is a pyrrolopyrimidine-based irreversible EGFR inhibitor that is mutation-selective with IC50 value of 0.18 nM against EGFR L858R/T790M double mutations, nearly 43-fold greater potency over wild-type EGFR (IC50 value, 7.68 nM). It has comparable anti-tumor activity and tolerated toxicity. Learn More
  40. Lazertinib (YH25448,GNS-1480)

    Catalog No. A16827
    Quick View
    EGFR inhibitor
    Lazertinib (YH25448,GNS-1480) is a potent, highly mutant-selective and irreversible EGFR-TKI with IC50 values of 1.7 nM, 2 nM, 5 nM, 20.6 nM and 76 nM for Del19/T790M, L858R/T790M, Del19, L85R and Wild type EGFR respectively, showing much higher IC50 values aganist ErbB2 and ErbB4. Learn More
  41. Tyrphostin AG-528

    Catalog No. A17072
    Quick View
    EGFR inhibitor
    Tyrphostin AG-528, also known as Tyrphostin B66, is a EGFR protein tyrosine kinase inhibitor. Learn More
  42. Pyrotinib Racemate

    Catalog No. A17068
    Quick View
    EGFR/HER2 dual inhibitor
    Pyrotinib Racemate is the racemate of Pyrotinib. Pyrotinib is a potent and selective EGFR/HER2 dual inhibitor. Learn More
    • New

    AG-494

    Catalog No. A17142
    Quick View
    EGFR inhibitor
    AG-494 is an inhibitor of epidermal growth factor receptor kinase with an IC50 value of 1 μM in HT-22 cells. Learn More
  43. Lavendustin A

    Catalog No. A17119
    Quick View
    EGFR inhibitor
    Lavendustin A is a selective inhibitor of epidermal growth factor (EGF) receptor-associated tyrosine kinase with IC50 value of 11 nM). Learn More
  44. AG-99

    Catalog No. A17123
    Quick View
    EGFR inhibitor
    AG-99 is an epidermal growth factor receptor (EGFR) kinase inhibitor with IC50 value of 10 μM. Learn More
  45. AG 555

    Catalog No. A18337
    Quick View
    EGFR inhibitor
    AG555 is a potent epidermal growth factor receptor (EGFR) kinase inhibitor. Learn More
  46. RG14620

    Catalog No. A18327
    Quick View
    EGFR inhibitor
    RG14620 is an EGFR inhibitor with an IC50 of 3 μM. Learn More
  47. MTX-211

    Catalog No. A18324
    Quick View
    EGFR/PI3K dual inhibitor
    MTX-211 is a dual inhibitor of EGFR and PI3K, which plays important roles in the progression of KRAS mutant colorectal cancer. MTX-211 has the potential for the treatment of KRAS mutant colorectal cancer. Learn More
  48. DBPR112

    Catalog No. A18857
    Quick View
    EGFR inhibitor
    DBPR112 is an orally active Furanopyrimidine-Based Epidermal Growth Factor Receptor inhibitor with IC50s of 15 nM and 48 nM for EGFRWT and EGFRL858R/T790M, respectively. Learn More
  49. EGFR-IN-7

    Catalog No. A18562
    Quick View
    EGFR inhibitor
    EGFR-IN-7 (compound 34) is a selective and potent EGFR kinase inhibitor extracted from patent WO2019015655A1, has IC50s of 7.92 nM and 0.218 nM for EGFR (WT) and EGFR (mutant C797S/T790M/L858R) respectively, and shows anti-tumor activity. Learn More

Items 151 to 200 of 218 total

per page
Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Set Descending Direction
Rewards